Offered by Université Laval in Québec, Canada, Pharmaceutical Sciences - Pharmacoepidemiology (PhD) is a doctorate in Epidemiology programme. The programme runs for 4 years.
At a glance
Degree:Doctorate
Field:Epidemiology
Duration: 4 years
We have no tuition fees or an application deadline on record for this programme yet — see the official programme page.
— it helps other students.
This PhD programme provides specialised research training in pharmacoepidemiology, the study of medication use, effectiveness, risks, and benefits across real-world populations. Students learn to design, plan, and conduct pharmacoepidemiological studies, developing expertise in treatment adherence, medication safety, healthcare interventions, and pharmacovigilance. The programme totals 90 credits and is completed full-time over an estimated four years, combining coursework in research methods with an original doctoral thesis carried out under faculty supervision. Most instruction is on campus, though some courses are offered at a distance. Graduates are prepared for research careers in academic, industrial, hospital, or government settings, or as scientific advisors. The credential awarded is a Philosophiae Doctor (Ph.D.) from Universite Laval's Faculty of Pharmacy.
Requirements
Minimum GPA:3.00 / 4.33
Admission Requirements: Applicants must hold a master's degree in pharmaceutical sciences with a pharmacoepidemiology focus, or an equivalent qualification; graduates of related disciplines such as epidemiology, medicine, pharmacology, psychology, or sociology may also qualify, with preparatory coursework required in some cases. A minimum GPA of 3.00 on a 4.33 scale is required, though candidates scoring 2.67-2.99 may apply for individual consideration. Applicants must secure a research supervisor's written commitment before submitting their application. Non-francophone applicants must achieve a TCF-TP score of at least 600/699 with at least 14/20 on written expression, or complete equivalent coursework.
